Experimental Ovarian Cancer Vaccine Shows Promise in Mice

The vaccine targets a protein found at elevated levels in about 90% of the most common type of ovarian cancer. If validated in human studies, researchers believe the vaccine may be particularly useful for women who carry BRCA1 and BRCA2 gene mutations.

from Cancer via ola Kala on Inoreader http://ift.tt/2iqGOvc
via IFTTT